非酒精性脂肪性肝病与心外膜脂肪组织关系的Meta分析

王向红; 马葆华; 邹秀兰; 姚克铖; 贺茜

doi:10.3969/j.issn.1001-5256.2020.06.023

非酒精性脂肪性肝病与心外膜脂肪组织关系的Meta分析

DOI: 10.3969/j.issn.1001-5256.2020.06.023

1. 三峡大学人民医院.宜昌市第一人民医院老年病科
2. 三峡大学人民医院.宜昌市第一人民医院内分泌科

基金项目:

湖北省教育厅人文社会科学研究重点项目(18D023)；湖北省卫生健康委员会2019-2020年度面上项目(WJ2019M064)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 994
- HTML全文浏览量: 72
- PDF下载量: 190
- 被引次数: 0
出版历程
- 出版日期: 2020-06-20

Association between nonalcoholic fatty liver disease and epicardial adipose tissue: A Meta-analysis

Research funding:

摘要

摘要:
目的评价非酒精性脂肪性肝病(NAFLD)与心外膜脂肪组织(EAT)的相关性。方法计算机检索PubMed、Embase、Web of Science、万方、中国知网等数据库,检索时间为自建库起至2019年1月1日,收集关于EAT厚度或体积与NAFLD相关性文献。采用Stata12. 0软件计算标准化均数差(SMD)及95%可信区间(95%CI),I2检验评估研究间的异质性,采用敏感性分析和亚组分析来探讨异质性来源。采用漏斗图、Begg’s检验和Egger’s检验评价发表偏倚。结果共纳入13篇文献,共包含4672例受试者,其中正常对照组2586例,NAFLD组2086例。NAFLD组较正常对照组EAT明显增加(SMD=0. 58,95%CI:0. 39～0. 77,P<0. 001)。NAFLD组与正常对照组在EAT厚度和EAT体积方面均存在差异(EAT厚度:SMD=0. 61,95%CI:0. 40～0. 83,P <0. 001; EAT体积:SMD=0. 47,95%CI:0. 17～0. 76,P=0. 002)。亚洲人群NAFLD与正常对照组比较,EAT增加,差异有...
- 非酒精性脂肪性肝病 /
- 心包 /
- Meta分析(主题)
Abstract:
Objective To investigate the association between nonalcoholic fatty liver disease( NAFLD) and epicardial adipose tissue( EAT). Methods Databases including PubMed,Embase,Web of Science,Wanfang Data,and CNKI were searched for the articles on the association of thickness and volume of EAT with NAFLD published up to January 1,2019. Stata12. 0 was used to calculate standardized mean difference( SMD) and 95% confidence interval( CI); the I2 test was used to evaluate heterogeneity between studies,and sensitivity analysis and subgroup analysis were used to explore the source of heterogeneity. Results A total of 13 articles were included,with 4672 subjects in total( 2586 subjects in the normal control group and 2086 subjects in the NAFLD group). The NAFLD group had a significant increase in EAT compared with the normal control group( SMD = 0. 58,95% CI: 0. 39-0. 77,P < 0. 001). There were significant differences between the NAFLD group and the normal control group in the thickness and volume of EAT( thickness: SMD = 0. 61,95% CI:0. 40-0. 83,P < 0. 001; volume: SMD = 0. 47,95% CI: 0. 17-0. 76,P = 0. 002). As for the Asian population,compared with the normal control group,the NAFLD group had a significant increase in EAT( SMD = 0. 37,95% CI: 0. 06-0. 68,P = 0. 018); as for the European/American population,compared with the normal control group,the NAFLD group had a significant increase in EAT( SMD = 0. 66,95% CI: 0. 40-0. 92,P < 0. 001). Compared with the normal control group,the NAFLD patients aged ≥50 years had a significant increase in EAT( SMD = 0. 46,95% CI: 0. 31-0. 62,P < 0. 001); there was a significant difference in EAT between the NAFLD patients aged < 50 years and the normal control group( SMD = 0. 72,95% CI: 0. 37-1. 06,P < 0. 001). The NAFLD patients with a body mass index( BMI) of ≥30 kg/m2 had significantly thicker EAT than the normal control group( SMD = 0. 79,95% CI: 0. 43-1. 15,P < 0. 001); the NAFLD patients with a BMI of < 30 kg/m2 also had significantly thicker EAT than the normal control group( SMD = 0. 42,95% CI: 0. 21-0. 62,P < 0. 001). Compared with the normal control group,the NAFLD patients undergoing radiological examination had a significant increase in EAT( SMD = 0. 44,95% CI: 0. 26-0. 63,P < 0. 001); compared with the normal control group,the NAFLD patients undergoing liver biopsy also had a significant increase in EAT( SMD = 1. 05,95% CI: 0. 82-1. 29,P < 0. 001). Publication bias was assessed by funnel plots( symmetric),Begg's test( P = 0. 583),and the Egger's test( P = 0. 126),and the results showed high reliability. Conclusion NAFLD is significantly associated with EAT cardiovascular risk factors,which will help NAFLD patients to establish effective strategies for the prevention and control of cardiovascular events.
- non-alcoholic fatty liver disease /
- pericardium /
- Meta-analysis as topic

HTML全文

参考文献(33)

[1] FOTBOLCU H,YAKAR T,DUMAN D,et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease[J]. Cardiol J,2010,17(5):457-463.

[2] LI J. Epidemiology characteristics of nonalcoholic fatty liver disease in Asia[J]. J Clin Hepatol,2018,34(12):2515-2519.(in Chinese)李婕．亚洲地区非酒精性脂肪性肝病的流行病学特点[J]．临床肝胆病杂志，2018,34(12):2515-2519.

[3] ANGULO P. GI epidemiology:Nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther,2007,25(8):883-889.

[4] MUSSO G,GAMBINO R,BO S,et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects[J].Diabetes Care,2008,31(3):562-568.

[5] SOOKOIAN S,BURGUEO AL,CASTAO G,et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects:Response to Musso et al[J]. Diabetes Care,2008,31(5):e42-e43.

[6] DOWMAN JK,TOMLINSON JW,NEWSOME PN. Pathogenesis of non-alcoholic fatty liver disease[J]. QJM,2010,103(2):71-83.

[7] AMPUERO J,GALLEGO-DURN R,ROMERO-GMEZ M.Association of NAFLD with subclinical atherosclerosis and coronary-artery disease:Meta-analysis[J]. Rev Esp Enferm Dig,2015,107(1):10-16.

[8] CHEUNG CL,LAM KS,WONG IC,et al. Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA[J]. BMC Med,2014,12:154.

[9] IACOBELLIS G,CORRADI D,SHARMA AM. Epicardial adipose tissue:Anatomic,biomolecular and clinical relationships with the heart[J]. Nat Clin Pract Cardiovasc Med,2005,2(10):536-543.

[10] IACOBELLIS G,BIANCO AC. Epicardial adipose tissue:Emerging physiological, pathophysiological and clinical features[J]. Trends Endocrinol Metab,2011,22(11):450-457.

[11] CHO KI,JO EA,CHO SH,et al. The influence of epicardial fat and nonalcoholic fatty liver disease on heart rate recovery in metabolic syndrome[J]. Metab Syndr Relat Disord,2017,15(5):226-232.

[12] PSYCHARI SN,REKLEITI N,PAPAIOANNOU N,et al. Epicardial fat in nonalcoholic fatty liver disease:Properties and relationships with metabolic factors,cardiac structure,and cardiac function[J]. Angiology,2016,67(1):41-48.

[13] OGˇUZ D，NAL H，EROGˇLU H,et al. Aortic flow propagation velocity,epicardial fat thickness,and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease[J]. Anatol J Cardiol,2016,16(12):974-979.

[14] SUNBUL M,AGIRBASLI M,DURMUS E,et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness[J]. Atherosclerosis,2014,237(2):490-493.

[15] IACOBELLIS G,BARBARINI G,LETIZIA C,et al. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects[J]. Obesity(Silver Spring),2014,22(2):332-336.

[16] ALP H,KARAARSLAN S,SELVER EKLIOGˇLU B,et al. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents[J]. Can J Cardiol,2013,29(9):1118-1125.

[17] COLAK Y,KARABAY CY,TUNCER I,et al. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease[J]. Eur J Gastroenterol Hepatol,2012,24(6):613-618.

[18] YILMAZ Y,KURT R,GURDAL A,et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease[J]. Atherosclerosis,2011,217(1):125-129.

[19] KIM BJ,CHEONG ES,KANG JG,et al. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification:From the CAESAR study[J]. J Clin Lipidol,2016,10(3):619-626. e1.

[20] FRACANZANI AL,PISANO G,CONSONNI D,et al. Epicardial adipose tissue(EAT)thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease[J]. PLo S One,2016,11(9):e0162473.

[21] BROUHA SS,NGUYEN P,BETTENCOURT R,et al. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes:A prospective study[J]. Eur Radiol,2018,28(4):1345-1355.

[22] GRANR M,NYMAN K,SIREN R,et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease[J]. Circ Cardiovasc Imaging,2015,8(1):e001979.

[23] CHEN ZH,YANG WJ,YAN FH. The correlation of visceral adipose tissue volume and other rontine obesity indexes with nonalcoholic fatty liver disease[J]. Radiol Pract,2017,32(5):436-440.(in Chinese)陈炽华，杨文洁，严福华．内脏脂肪体积及常见肥胖指标与非酒精性脂肪肝的相关性研究[J]．放射学实践，2017,32(5):436-440.

[24] LONARDO A,SOOKOIAN S,PIROLA CJ,et al. Non-alcoholic fatty liver disease and risk of cardiovascular disease[J].Metabolism,2016,65(8):1136-1150.

[25] TARGHER G. Non-alcoholic fatty liver disease as driving force in coronary heart disease?[J]. Gut,2017,66(2):213-214.

[26] TARGHER G,BYRNE CD,LONARDO A,et al. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease:A meta-analysis[J]. J Hepatol,2016,65(3):589-600.

[27] LI Q,ZHUO QB,CHEN L,et al. Research advances in association between non-alcoholic fatty liver disease and cardiovascular disease[J]. J Clin Hepatol,2015,31(7):1046-1049.(in Chinese)李强，卓其斌，陈良，等．非酒精性脂肪性肝性与心血管疾病的相关性[J]．临床肝胆病杂志，2015,31(7):1046-1049.

[28] FAN Y,WEI F,ZHOU Y,et al. Association of non-alcoholic fatty liver disease with impaired endothelial function by flowmediated dilation:A meta-analysis[J]. Hepatol Res,2016,46(3):e165-e173.

[29] SOOKOIAN S,PIROLA CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis:A systematic review[J]. J Hepatol,2008,49(4):600-607.

[30] MARCHESINI G,BRIZI M,BIANCHI G,et al. Nonalcoholic fatty liver disease:A feature of the metabolic syndrome[J].Diabetes,2001,50(8):1844-1850.

[31] GRUZDEVA OV,AKBASHEVA OE,DYLEVA YA,et al. Adipokine and cytokine profiles of epicardial and subcutaneous adipose tissue in patients with coronary heart disease[J]. Bull Exp Biol Med,2017,163(5):608-611.

[32] DU YY,LIU Y,LU M,et al. Expressions of adiponectin-related miR-371b-5p in epicardial adipose tissue and plasma of patients with coronary heart disease and its effect on secretion of adipocytokines[J]. J Jilin Univ(Med Edit),2019,45(3):643-650,after insert 6.(in Chinese)杜雅彦，刘洋，卢沐，等．冠心病患者心外膜脂肪组织和血浆中脂联素相关miR-371b-5p表达及其对脂肪细胞因子分泌的影响[J]．吉林大学学报(医学版)，2019,45(3):643-650，后插6.

[33] EROGˇLU S,SADE LE,YILDIRIR A,et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease[J]. Nutr Metab Cardiovasc Dis,2009,19(3):211-217.

施引文献

资源附件(0)

访问统计